RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population
COVID-19GAOM
1 other identifier
observational
100
1 country
1
Brief Summary
Evaluation of the rate of positive RT-PCR SARS-CoV-2 test at 1 month of COVID infection among elderly people. It is unclear how long an individual with COVID-19 will remain "sick" and "contagious". It appears that SARS-CoV-2 can be transmitted before symptoms appear and throughout the course of the disease. They investigators did not find any study on a COVID + geriatric population reassessing carriage at 1 month even though age seems to be a risk factor for prolonged excretion as suggested in the study following study: Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clinical Infectious Diseases. 2020 Apr 9; ciaa351
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 7, 2020
CompletedFirst Submitted
Initial submission to the registry
June 10, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2020
CompletedNovember 25, 2020
June 1, 2020
3 months
June 10, 2020
November 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
1. Analysis of the rate of RT-PCR SARS-CoV-2 positive at 1 month of COVID infection
at 1 month of COVID infection]
2. Assess quantitative evaluation of a nasopharyngeal swab SARS-CoV-2 RT-PCR test
The objective of this study is to quantitatively assess viral shedding in COVID-19 infected elderly patients who survived infection in order to provide an overview of the evolution of nasopharyngeal swab SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test results with the Cycle threshold value of the RT-PCR test.. The investigatrors analyze nasopharyngeal RT-PCR at diagnosis. After one month since the date of onset symptoms they reassessed survival patients with nasopharyngeal RT-PCR and repeat the RT-PCR at least every week until final negative conversion occurs.
at 1 month after COVID infection
Secondary Outcomes (1)
Assessment of late stool SARS-CoV-2 RT-PCR, serological status and associated factors with death and RT-PCR results 1 month after the date of first symptom onset
1 month after the date of first symptom onset
Eligibility Criteria
Patient over 70 years age having COVID-19
You may qualify if:
- Age\> 70years
- Patient hospitalized on the geriatric center from March 1, 2020 to August 1, 2020 with a diagnosis of COVID-19 still alive at 1 month.
- Patient having agreed to the re-use of their data for the purposes of this research
You may not qualify if:
- Subject who expressed his opposition to participate in the study
- Subject under judicial protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service SSR Gériatrique
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2020
First Posted
June 11, 2020
Study Start
May 7, 2020
Primary Completion
August 7, 2020
Study Completion
September 7, 2020
Last Updated
November 25, 2020
Record last verified: 2020-06